
Work Here?
Vilya uses a computational biotechnology platform, built on research from the Institute of Protein Design, to create a new class of medicines. It designs drug candidates with advanced computer methods that model proteins and other biological targets, aiming to precisely influence disease biology. The company advances its own therapeutic pipeline and/or partners with pharmaceutical companies to bring these candidates to patients. What sets Vilya apart is its focus on computational drug design and protein design to rapidly generate novel medicines that target disease at the molecular level, rather than relying solely on traditional lab discovery. The main goal is to expand the set of medicines available by developing and deploying computationally designed therapeutics across multiple disease areas.
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$71M
Headquarters
Seattle, Washington
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$71M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Stock Options
Unlimited Paid Time Off
Phone/Internet Stipend
Wellness Program
Commuter Benefits
Conference Attendance Budget
Data from GeekWire’s fundings list.Tech startups spanning biotech, agriculture, healthcare, autonomous vehicles, and other industries reeled in the largest funding rounds during the second quarter this year across the Pacific Northwest.Total venture capital raised in Q2 came in at $382 million across 34 deals, according to GeekWire’s funding tracker. That dollar value is just below the previous quarter; down nearly 50% from the year-ago period; and not even in the same hemisphere as the second quarter of 2022, when 63 companies raised a collective $2.1 billion.It’s a new world for startups. The era of growth-at-all-costs and plentiful venture capital dollars are long gone, following record-breaking boom times just a few years ago.As we wrote last month, “default alive” is the mindset for many companies under pressure from investors to demonstrate a path to profitability. Investors are focused on “supporting their most promising companies to maturity amid a historically challenging exit environment,” said Bobby Franklin, CEO of the National Venture Capital Association, in a new PitchBook-NVCA Venture Monitor released Thursday. “This has meant more inside and continuation rounds with valuations under unprecedented levels of scrutiny.”(Image via CBInsights)But many investors have cash they need to invest, and some startups are still raising.AI startups are gobbling a big chunk of funding these days, raising nearly a third of all dollars during the second quarter, according to CBInsights.That trend is reflected in the Pacific Northwest, where several of the top rounds in Q2 went to startups focused heavily on AI technologies. The Seattle region didn’t crack the top 10 among metropolitan areas ranked by total funding raised in Q2, according to PitchBook
Concurrent with this financing, Menlo Ventures' Partner Greg Yap joined the Vilya board.
Vilya, a biotechnology company, announced an expanded $71 million Series A financing to advance its computational drug design platform and develop novel macrocycles. The funding, led by ARCH Venture Partners and joined by NVentures, Menlo Ventures, Madrona, Lifeforce Capital, and Altitude Life Science Ventures, will enhance Vilya's generative AI platform and accelerate the development of clinical candidates. CEO Cyrus Harmon highlighted the support's role in broadening design and synthesis capabilities.
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Golston, president of the U.S. Program for the Bill & Melinda Gates Foundation. (Icertis Photo).— Allan Golston joined the board of directors at Bellevue, Wash.-based contract lifecycle management company Icertis. He has served as the president of the Bill & Melinda Gates Foundation for more than 17 years. Golston also sits on the board of Stryker Corporation and Harley-Davidson.— Costco announced Wednesday that CEO Craig Jelinek will step down
Vilya appoints Cyrus Harmon, Ph.D., as Chief Executive Officer.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$71M
Headquarters
Seattle, Washington
Founded
2022
Find jobs on Simplify and start your career today